Harding Loevner’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317M | Buy |
|
|||||
|
2025
Q1 | $339M | Sell |
|
|||||
|
2024
Q4 | $332M | Sell |
|
|||||
|
2024
Q3 | $536M | Sell |
|
|||||
|
2024
Q2 | $555M | Sell |
|
|||||
|
2024
Q1 | $511M | Sell |
|
|||||
|
2023
Q4 | $539M | Sell |
|
|||||
|
2023
Q3 | $468M | Sell |
|
|||||
|
2023
Q2 | $541M | Sell |
|
|||||
|
2023
Q1 | $576M | Sell |
|
|||||
|
2022
Q4 | $532M | Buy |
|
|||||
|
2022
Q3 | $475M | Sell |
|
|||||
|
2022
Q2 | $489M | Sell |
|
|||||
|
2022
Q1 | $417M | Sell |
|
|||||
|
2021
Q4 | $413M | Sell |
|
|||||
|
2021
Q3 | $347M | Sell |
|
|||||
|
2021
Q2 | $403M | Buy |
|
|||||
|
2021
Q1 | $426M | Sell |
|
|||||
|
2020
Q4 | $483M | Buy |
|
|||||
|
2020
Q3 | $544M | Sell |
|
|||||
|
2020
Q2 | $587M | Sell |
|
|||||
|
2020
Q1 | $487M | Sell |
|
|||||
|
2019
Q4 | $458M | Sell |
|
|||||
|
2019
Q3 | $394M | Buy |
|
|||||
|
2019
Q2 | $136M | Sell |
|
|||||
|
2019
Q1 | $138M | Buy |
|
|||||
|
2018
Q4 | $11K | Buy |
|